Anticancer Drugs Course
This Anticancer Drugs Course equips oncology professionals with practical knowledge on first-line EGFR TKI strategies for EGFR-mutated NSCLC. Participants learn to manage toxicities effectively, address resistance through targeted approaches, chemotherapy, or trials, and communicate clearly with patients to improve treatment outcomes and decision-making confidence.

from 4 to 360h flexible workload
valid certificate in your country
What will I learn?
Gain a practical overview of first-line systemic treatments for EGFR-mutated NSCLC, covering targeted therapies, chemo-immunotherapy, and chemotherapy. Master mechanisms of action, dosing schedules, toxicity profiles, prevention and management techniques, resistance mechanisms, second-line therapies, monitoring protocols, and patient communication skills for evidence-based decisions.
Elevify advantages
Develop skills
- Select EGFR TKI first-line regimens based on latest trial evidence.
- Plan imaging, re-biopsy, and liquid biopsy for resistance evaluation.
- Match resistance to targeted therapy, chemotherapy, or trials.
- Prevent and manage EGFR TKI rash, diarrhea, ILD, and cytopenias.
- Counsel patients on goals, side effects, and progression clearly.
Suggested summary
Before starting, you can change the chapters and the workload. Choose which chapter to start with. Add or remove chapters. Increase or decrease the course workload.What our students say
FAQs
Who is Elevify? How does it work?
Do the courses have certificates?
Are the courses free?
What is the course workload?
What are the courses like?
How do the courses work?
What is the duration of the courses?
What is the cost or price of the courses?
What is an EAD or online course and how does it work?
PDF Course